Lattice Biologics to launch three MAR products — 3 highlights

Written by Allison Sobczak | April 26, 2016 | Print  |

Lattice Biologics is scheduled to launch three new products utilizing its patent-pending matrix-assisted regeneration platform.

Here are three highlights:


1. The new products, MarBrane, MarGraft and MarCell are anticipated to significantly accelerate the company's top line revenue growth.


2. MarBrane and MarGraft are expected to launch in second quarter of 2016. MarCell is expected to launch in the third quarter of 2016.


3. Based in Scottsdale, Ariz., Lattice Biologics develops and manufactures biologic products used in a variety of applications, such as spine surgery, orthopedics and sports medicine, among others.


More articles on devices and implants:
Bone Biologics completes $5M+ financing round: 3 things to know
RTI Surgical launches laminoplasty fixation system: 4 key notes
Pinnacle Spine Group receives Chinese patent for spinal fusion technology: 4 notes

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers